INVO Bioscience, Inc. (INVO)
| Market Cap | 34.44M |
| Revenue (ttm) | 1.43M |
| Net Income (ttm) | -9.85M |
| Shares Out | 10.50M |
| EPS (ttm) | -1.22 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 58,734 |
| Open | 3.29 |
| Previous Close | 3.33 |
| Day's Range | 3.25 - 3.39 |
| 52-Week Range | 2.90 - 12.30 |
| Beta | -1.14 |
| Analysts | Buy |
| Price Target | 5.63 (+71.6%) |
| Est. Earnings Date | Nov 15, 2021 |
About INVO
INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.
Financial Performance
In 2020, INVO's revenue was $1.04 million, a decrease of -29.92% compared to the previous year's $1.48 million. Losses were -$8.35 million, 285.1% more than in 2019.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.63, which is an increase of 71.65% from the latest price.
News
INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada
SARASOTA, Fla., Sept. 9, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, an affor...
INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta
SARASOTA, Fla. and ATLANTA, Sept.
Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual...
SARASOTA, Fla., Sept. 3, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, announce...
Invo BioScience Inc. (INVO) Reports Q2 Loss, Lags Revenue Estimates
Invo BioScience Inc. (INVO) delivered earnings and revenue surprises of 10.53% and -0.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
SARASOTA, Fla., Aug. 16, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and develo...
Invo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Invo BioScience Inc. (INVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
SARASOTA, Fla., Aug. 5, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, an effect...
INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama
SARASOTA, Fla., Aug. 2, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today ann...
INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration
SARASOTA, Fla., July 14, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, an effec...
INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta
SARASOTA, Fla. and ATLANTA, June 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcel...
INVO Bioscience Appoints Andrea Goren as Chief Financial Officer
SARASOTA, Fla., June 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...
New Strong Sell Stocks for May 21st
ATHM, INVO, FOUR, KRYS, and RMAX have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2021
INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
SARASOTA, Fla., May 17, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and develop...
INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
SARASOTA, Fla., May 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion
SARASOTA, Fla., May 10, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...
INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
SARASOTA, Fla., April 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awa...
SARASOTA, Fla., April 22, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California
SARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture S...
New Strong Sell Stocks for April 16th
VNET, ALTG, FPI, HALL, and INVO have been added to the Zacks Rank #5 (Strong Sell) List on April 16, 2021
INVO Bioscience to Present at Tribe Public Event on April 13, 2021
SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...
INVO Bioscience Reports 2020 Financial Results
SARASOTA, Fla., March 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...
INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference
SARASOTA, Fla., March 29, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021
SARASOTA, Fla., March 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United St...
SARASOTA, Fla. and BIRMINGHAM, Ala.
INVO Bioscience to Participate in the 33rd Annual Roth Conference
SARASOTA, Fla., March 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...